Cool new development that will improve schizophrenia research and get better therapies for everyone:
It’s a milestone in medical progress: a company has finally pushed the cost of sequencing the human genome down to $1000. But don’t bother rushing to order your spit test, at least not just yet.
Even if the manufacturer of the newly announced $1000 test, Illumina of San Diego, California, were making the technology available to the public – which it isn’t – there would be no point for most of us. Rather than helping healthy individuals assess their risk of disease, the immediate reasons to cheer the breakthrough are that it should help us to decode a bunch of complex diseases, including diabetes and schizophrenia.